Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatitis B virus surface antigen seroconversion after pegylated interferon-alpha treatment in an HIV-infected individual with chronic hepatitis B.

× No keyword cloud information.

14 in total

1. Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues.

Authors: Luz Martín-Carbonero; Tiago Teixeira; Eva Poveda; Zulema Plaza; Eugenia Vispo; Juan González-Lahoz; Vincent Soriano
Journal: AIDS Date: 2011-01-02 Impact factor: 4.177

2. A new role for an old marker, HBsAg.

Authors: Maurizia Rossana Brunetto
Journal: J Hepatol Date: 2010-01-30 Impact factor: 25.083

3. Temporary HBV resolution in an HIV-coinfected patient during HBV-directed combination therapy followed by relapse of HBV.

Authors: Karsten Wursthorn; Peter Buggisch; Marc Lutgehetmann; Bernhard Zollner; Jorg Petersen
Journal: Antivir Ther Date: 2006

4. Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy.

Authors: Marina Núñez; Belén Ramos; Beatriz Díaz-Pollán; Nuria Camino; Luz Martín-Carbonero; Pablo Barreiro; Juan González-Lahoz; Vincent Soriano
Journal: AIDS Res Hum Retroviruses Date: 2006-09 Impact factor: 2.205

Review 5. Epidemiology of viral hepatitis and HIV co-infection.

Authors: Miriam J Alter
Journal: J Hepatol Date: 2005-11-21 Impact factor: 25.083

6. Complete cure of HBV-HDV co-infection after 24weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV.

Authors: Joel Gozlan; Karine Lacombe; Elyanne Gault; Gilles Raguin; Pierre-Marie Girard
Journal: J Hepatol Date: 2008-12-06 Impact factor: 25.083

7. Sustained elimination of hepatitis B virus from serum induced in a patient with chronic hepatitis B and advanced human immunodeficiency virus infection.

Authors: T Wölfel; P Schirmacher; J Schlaak; P Knolle; H P Dienes; W Dippold; K H Meyer zum Büschenfelde; G Gerken
Journal: Clin Investig Date: 1994-12

8. Recombinant alpha interferon for chronic hepatitis B in anti-HIV positive patients receiving zidovudine.

Authors: P Marcellin; N Boyer; J F Colin; M Martinot-Peignoux; V Lefort; S Matheron; S Erlinger; J P Benhamou
Journal: Gut Date: 1993 Impact factor: 23.059

9. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.

Authors: J K Rockstroh; S Bhagani; Y Benhamou; R Bruno; S Mauss; L Peters; M Puoti; V Soriano; C Tural
Journal: HIV Med Date: 2008-02 Impact factor: 3.180

Review 10. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses.

Authors: S A Kalams; B D Walker
Journal: J Exp Med Date: 1998-12-21 Impact factor: 14.307

1 in total

1. Hepatitis B virus surface antigen seroconversion in HIV-infected individual after pegylated interferon-alpha treatment: a case report.

Authors: Adriane Maira Delicio; Paulo Afonso Martins Abati; Aline Gonzalez Vigani
Journal: J Venom Anim Toxins Incl Trop Dis Date: 2013-12-10

1 in total